Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2026-01-19 @ 9:16 AM
Study NCT ID:
NCT00635557
Status:
UNKNOWN
Last Update Posted:
2011-03-25
First Post:
2008-03-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
Sponsor:
Myrexis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MPC-6827-07-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Andrew P. Beelen, MD / Sr. Director of Clinical Research
Old Organization:
Myrexis Inc.